Retention Rates and Reasons for Non-retention in Exercise Oncology Trials in the Post-treatment Phase-a Systematic Review

Overview

Journal J Cancer Surviv

Specialty Oncology

Date 2024 Apr 3

PMID 38570403

Authors

S Hu

E Guinan

D Mockler

L ONeill

Affiliations

Soon will be listed here.

Abstract

Purpose: Retention is a key marker of trial success. Poor retention can induce bias, reduce statistical power and minimise the validity of trials. This review examined retention rates in exercise trials in cancer survivors, reasons for non-retention and retention strategies utilised.

Methods: A systematic review was conducted using a predefined search strategy in EMBASE RCTs, MEDLINE OVID, CINAHL, Web of Science-Core Collection and Cochrane Central Register of Controlled Trials (CENTRAL). The search was conducted on 27/03/2023. Title and abstract screening, full text review and data extraction were completed in duplicate.

Results: Of 17,524 studies identified, 67 trials involving 6093 participants were included. The median overall retention rate immediately post-intervention was 89.85%, range (52.94-100%) and mean 87.36% (standard deviation 9.89%). Trials involving colorectal cancer survivors only had the highest median retention rate (94.61%), followed by breast (92.74%), prostate (86.00%) and haematological cancers (85.49%). Studies involving mixed cancer cohorts had the lowest retention rate (80.18%). The most common retention strategies were wait-list control groups, regular check-ins/reminders and free exercise equipment. Common reasons for non-retention were lost to follow-up, health problems, personal reasons including family/work commitments and travel burden, and disease progression.

Conclusions: Retention rates in exercise oncology trials are approximately 90% immediately post-interventions. Our previous work highlighted variable suboptimal recruitment rates of median 38% (range 0.52-100%). Recruitment rather than retention should be prioritised for methodology research in exercise oncology.

Implications For Cancer Survivors: Optimising the quality of exercise oncology trials is critical to informing high quality survivorship care. PROSPERO registration number: CRD42023421359.

Citing Articles

Feasibility, Acceptability, and Outcomes of Project Rally: Pilot Study of a YMCA-Based Pickleball Program for Cancer Survivors.

Parker N, de Cerqueira Santos A, Mintrone R, Turner K, Sutton S, OConnor T Healthcare (Basel). 2025; 13(3).

PMID: 39942445 PMC: 11817839. DOI: 10.3390/healthcare13030256.

References

Campbell K, Winters-Stone K, Wiskemann J, May A, Schwartz A, Courneya K . Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019; 51(11):2375-2390. PMC: 8576825. DOI: 10.1249/MSS.0000000000002116. View

Morris M, Crank H, Loosemore M, Stevinson C . Identification of Research Priorities in Exercise Oncology: A Consensus Study. J Cancer. 2020; 11(9):2702-2707. PMC: 7066012. DOI: 10.7150/jca.42992. View

Courneya K, Booth C . Exercise as cancer treatment: A clinical oncology framework for exercise oncology research. Front Oncol. 2022; 12:957135. PMC: 9480835. DOI: 10.3389/fonc.2022.957135. View

Tudur Smith C, Hickey H, Clarke M, Blazeby J, Williamson P . The trials methodological research agenda: results from a priority setting exercise. Trials. 2014; 15:32. PMC: 3904160. DOI: 10.1186/1745-6215-15-32. View

Gillies K, Kearney A, Keenan C, Treweek S, Hudson J, Brueton V . Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2021; 3:MR000032. PMC: 8092429. DOI: 10.1002/14651858.MR000032.pub3. View

Parkinson B, Meacock R, Sutton M, Fichera E, Mills N, Shorter G . Designing and using incentives to support recruitment and retention in clinical trials: a scoping review and a checklist for design. Trials. 2019; 20(1):624. PMC: 6842495. DOI: 10.1186/s13063-019-3710-z. View

Sheill G, Guinan E, Brady L, Hevey D, Hussey J . Exercise interventions for patients with advanced cancer: A systematic review of recruitment, attrition, and exercise adherence rates. Palliat Support Care. 2019; 17(6):686-696. DOI: 10.1017/S1478951519000312. View

West M, Loughney L, Lythgoe D, Barben C, Sripadam R, Kemp G . Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. Br J Anaesth. 2014; 114(2):244-51. DOI: 10.1093/bja/aeu318. View

Brunsdon D, Biesty L, Brocklehurst P, Brueton V, Devane D, Elliott J . What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials. 2019; 20(1):593. PMC: 6794792. DOI: 10.1186/s13063-019-3687-7. View

10.

Treweek S, Bevan S, Bower P, Campbell M, Christie J, Clarke M . Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?. Trials. 2018; 19(1):139. PMC: 5824570. DOI: 10.1186/s13063-018-2535-5. View

11.

Broderick J, Guinan E, Kennedy M, Hollywood D, Courneya K, Culos-Reed S . Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial. J Cancer Surviv. 2013; 7(4):551-62. DOI: 10.1007/s11764-013-0294-6. View

12.

Guinan E, Hussey J, Broderick J, Lithander F, ODonnell D, Kennedy M . The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study. Support Care Cancer. 2013; 21(7):1983-92. DOI: 10.1007/s00520-013-1743-5. View

13.

Sagen A, Karesen R, Risberg M . Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncol. 2009; 48(8):1102-10. DOI: 10.3109/02841860903061683. View

14.

Santa Mina D, Alibhai S M, Matthew A, Guglietti C, Pirbaglou M, Trachtenberg J . A randomized trial of aerobic versus resistance exercise in prostate cancer survivors. J Aging Phys Act. 2012; 21(4):455-78. DOI: 10.1123/japa.21.4.455. View

15.

Anderson R, Kimmick G, McCoy T, Hopkins J, Levine E, Miller G . A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial. J Cancer Surviv. 2011; 6(2):172-81. PMC: 3900279. DOI: 10.1007/s11764-011-0208-4. View

16.

Greenlee H, Crew K, Mata J, McKinley P, Rundle A, Zhang W . A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obesity (Silver Spring). 2013; 21(1):65-76. PMC: 4705911. DOI: 10.1002/oby.20245. View

17.

Pinto B, Papandonatos G, Goldstein M, Marcus B, Farrell N . Home-based physical activity intervention for colorectal cancer survivors. Psychooncology. 2011; 22(1):54-64. DOI: 10.1002/pon.2047. View

18.

McNeely M, Parliament M, Seikaly H, Jha N, Magee D, Haykowsky M . Sustainability of outcomes after a randomized crossover trial of resistance exercise for shoulder dysfunction in survivors of head and neck cancer. Physiother Can. 2015; 67(1):85-93. PMC: 4403331. DOI: 10.3138/ptc.2014-13O. View

19.

Brocki B, Andreasen J, Nielsen L, Nekrasas V, Gorst-Rasmussen A, Westerdahl E . Short and long-term effects of supervised versus unsupervised exercise training on health-related quality of life and functional outcomes following lung cancer surgery - a randomized controlled trial. Lung Cancer. 2013; 83(1):102-8. DOI: 10.1016/j.lungcan.2013.10.015. View

20.

Daley A, Crank H, Saxton J, Mutrie N, Coleman R, Roalfe A . Randomized trial of exercise therapy in women treated for breast cancer. J Clin Oncol. 2007; 25(13):1713-21. DOI: 10.1200/JCO.2006.09.5083. View